Srikar Chem & Pharma India Private Limited

Srikar Chem & Pharma India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24100TG2011PTC072439 Incorporated 01 February 2011 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2024
₹8.6 Cr
▼ 11% YoY
Net profit · FY 2024
₹16.31 Lakh
Net margin 1.9%
EBITDA · FY 2024
₹43.43 Lakh
EBITDA margin 5%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.46 Cr
Issued & subscribed
Company age
15 yrs
Est. 2011
Employees · EPFO
28
Provident fund records
Directors on board
2
As per MCA filings

About Srikar Chem & Pharma India Private Limited

Data last updated:

Srikar Chem & Pharma India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 February 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2011PTC072439. Its GSTIN is 37ABWFS7418K1Z8 (Andhra Pradesh).

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.46 Cr. It is led by directors Narravula Anuradha and Geyana Narravula.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dno:2 – 133/2 Flat No:215 Nirmal Ratna Apartments Gangaram Chandanagar, Hyderabad, Telangana, India – 500050.

As per the financials filed for FY 2024, the company reported a revenue of ₹8.6 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹16.31 Lakh (net margin 1.9%) and EBITDA of ₹43.43 Lakh (EBITDA margin 5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.

The company has about 28 employees on its provident fund (EPFO) records.

Srikar Chem & Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-01-0004381). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24100TG2011PTC072439
Registration Number 072439
Incorporation Date 01 February 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-01-0004381

CIN history

Srikar Chem & Pharma India has one previous CIN (Corporate Identification Number): U24100AP2011PTC072439. The current CIN is U24100TG2011PTC072439, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100TG2011PTC072439Current
U24100AP2011PTC072439Previous

Recognitions & Rankings of Srikar Chem & Pharma India

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-AP-01-0004381

Contact details

Srikar Chem & Pharma India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Dno:2 – 133/2 Flat No:215 Nirmal Ratna Apartments Gangaram Chandanagar, Hyderabad, Telangana, India – 500050
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Srikar Chem & Pharma India Private Limited, buy the company report.

Comprehensive company report
Srikar Chem & Pharma India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Srikar Chem & Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Srikar Chem & Pharma India Private Limited, buy the company report.

Financials of Srikar Chem & Pharma India Private Limited

FY 2025 filings available

Srikar Chem & Pharma India Private Limited reported revenue of ₹8.6 Cr (down 11% YoY) for FY 2024.

Revenue · FY 2024
₹8.6 Cr ▼ 11%
Net profit · FY 2024
₹16.31 Lakh margin 1.9%
EBITDA · FY 2024
₹43.43 Lakh margin 5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 5%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 24%
5 years · compounded
▼ 9%

Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 11% fall in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹43.43 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5%
Net Profit Margin1.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Srikar Chem & Pharma India Private Limited, buy the company report.

Board of directors of Srikar Chem & Pharma India Private Limited

Srikar Chem & Pharma India has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narravula AnuradhaDirector20 Nov 20196 Years 11 MonthsCurrent
Geyana NarravulaDirector20 Nov 20196 Years 11 MonthsCurrent

Peer comparison

Srikar Chem & Pharma India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pehal Life Sciences Private Limited₹8.66 Cr (FY 2024)-33.0%Mumbai, Maharashtra, India
Waxsen Lifescience Private Limited₹8.64 Cr (FY 2019)-50.0%Mumbai, Maharashtra, India
Srikar Chem & Pharma India Private Limitedthis company₹8.6 Cr (FY 2024)₹16.31 Lakh1.9%-11.0%28Hyderabad, Telangana, India
Zahidi Pharmaceuticals Private Limited₹8.6 Cr (FY 2025)2.0%Umbergaon, Gujarat, India
Kaizen Research Labs India Private Limited₹8.6 Cr (FY 2025)-17.0%Chennai, Tamil Nadu, India
Rebase Lifescience Private Limited₹8.59 Cr (FY 2025)8.0%Lalpur, Gujarat, India

To see the full peer comparison of Srikar Chem & Pharma India Private Limited, buy the company report.

Auditor

Srikar Chem & Pharma India Private Limited is audited by S T MOHITE & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
S T MOHITE & COFY 2019011410S

Shareholding

The shareholding of Srikar Chem & Pharma India Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Srikar Chem & Pharma India Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Srikar Chem & Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Srikar Chem & Pharma India Private Limited has a workforce of 28 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
28
Active EPFO establishments
1
Employee growth
33.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2728
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19

To see the full employee and EPFO history of Srikar Chem & Pharma India Private Limited, buy the company report.

GST

Srikar Chem & Pharma India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37ABWFS7418K1Z8Andhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Srikar Chem & Pharma India Private Limited, buy the company report.

Recent activity

Srikar Chem & Pharma India Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Geyana Narravula was appointed as Director on 20 Nov 2019.

AGM
Srikar Chem & Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Srikar Chem & Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Geyana Narravula was appointed as Director.
Appointed
Narravula Anuradha was appointed as Director.
Ceased
Narravula Ranganayakulu ceased to be Director.
Ceased
Geyana Narravula ceased to be Additional Director.
Ceased
Narravula Anuradha ceased to be Director.
Ceased
Nandakumar Peddareddygari ceased to be Additional Director.
Ceased
Jeelan Hindupur Abdul Khader ceased to be Additional Director.
Incorporation
01 Feb 2011
Srikar Chem & Pharma India Private Limited was registered on 01 Feb 2011 with Roc Hyderabad & aged 15 years 9 months as per MCA records.

Frequently asked questions

Srikar Chem & Pharma India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 February 2011 (15+ years old) and is registered under CIN U24100TG2011PTC072439.

Srikar Chem & Pharma India has 2 current directors:

The latest financial statements of Srikar Chem & Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Srikar Chem & Pharma India is 37ABWFS7418K1Z8, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Srikar Chem & Pharma India is U24100TG2011PTC072439. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Srikar Chem & Pharma India was incorporated on 01 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Srikar Chem & Pharma India by revenue are Pehal Life Sciences Private Limited, Waxsen Lifescience Private Limited, Zahidi Pharmaceuticals Private Limited, Kaizen Research Labs India Private Limited, Rebase Lifescience Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Geyana Narravula was appointed as Director on 20 Nov 2019. Narravula Anuradha was appointed as Director on 20 Nov 2019. Narravula Ranganayakulu ceased to be Director on 19 Nov 2019. Srikar Chem & Pharma India has 7 board changes on record in total.

Yes, Srikar Chem & Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-AP-01-0004381).

The registered office of Srikar Chem & Pharma India is at Dno:2 – 1332 Flat No:215 Nirmal Ratna Apartments Gangaram Chandanagar, Hyderabad, Telangana, India – 500050.

Srikar Chem & Pharma India operates in the pharma industry, in the drug formulation and development segment.